Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

Clinical trial NCT03171818 · UNKNOWN

Trial details

NCT number: NCT03171818
Sponsor: UMC Utrecht
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

PAIS Neonatal Stroke Perinatal Stroke

Start date: 2017-07-01
Primary completion: 2024-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.